Oral contraceptive effectiveness according to body mass index, weight, age, and other factors

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 3, 2009, Pages 263.e1-263.e9

  Dinger, Jürgen C ^a   Cronin, Maureen ^b   Möhner, Sabine ^a   Schellschmidt, Ilka ^b   Minh, Thai Do ^a   Westhoff, Carolyn ^c  

^a ZEG Berlin Center for Epidemiology and Health Research   (Germany)

^b BAYER PHARMA AG   (Germany)

^c Columbia University ^*  (United States)

Author keywords

body mass index; contraceptive effectiveness; oral contraceptives; weight

Indexed keywords

CHLORMADINONE ACETATE; DESOGESTREL; DIENOGEST; DROSPIRENONE; ETHINYLESTRADIOL; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG USE; EUROPE; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; PARITY; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT DURATION; UNPLANNED PREGNANCY;

EID: 69349094031     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.03.017     Document Type: Article

References (27)

1. Trussell J. Contraceptive efficacy. In: Hatcher R.A., Trussell J., Nelson A.L., Cates W., Stewart F.H., and Kowal D. (Eds). Contraceptive technology. 18th ed. (2007), Ardent Media, New York 792
2. Food and Drug Administration. Transcript: Advisory Committee for Reproductive Health Drugs, January 24, 2007. http://www.fda.gov/OHRMS/DOCKETS/AC/07/transcripts/2007-4274t2-part2.pdf Accessed Jan. 7, 2009
3. Brunner Huber L.R., and Hogue C.J. The association between body weight, unintended pregnancy resulting in a livebirth, and contraception at the time of conception. Matern Child Health J 9 (2005) 413-420
4. Holt V.L., Cushing-Haugen K.L., and Daling J.R. Body weight and risk of oral contraceptive failure. Obstet Gynecol 99 (2002) 820-827
5. Holt V.L., Scholes D., Wicklund K.G., Cushing-Haugen K.L., and Daling J.R. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 105 (2005) 46-52
6. Brunner Huber L.R., Hogue C.J., Stein A.D., Drews C., and Zieman M. Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina. Ann Epidemiol 16 (2006) 637-643
7. Brunner Huber L.R., and Toth J.L. Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth. Am J Epidemiol 166 (2007) 1306-1311
8. Brunner L.R., and Hogue C.J. The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth. Ann Epidemiol 15 (2005) 492-499
9. Vessey M. Oral contraceptive failures and body weight: findings in a large cohort study. J Fam Plann Reprod Health Care 27 (2001) 90-91
10. Dinger J.C., Heinemann L.A.J., and Kühl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation. Contraception 75 (2007) 344-354
11. European Medicines Agency Committee for Medicinal Products for Human Use. Guideline on clinical investigation of steroid contraceptives in women, July 27, 2005. http://www.emea.europa.eu/pdfs/human/ewp/051998en.pdf Accessed Jan. 6, 2009
12. Gerlinger C., Endrikat J., van der Meulen E.A., Dieben T.O., and Dusterberg B. Recommendation for confidence interval and sample size calculation for the Pearl Index. Eur J Contracept Reprod Health Care 8 (2003) 87-92
13. Gallegos A.J., Gonzáles-Diddi M., Merino G., and Martínez-Manautou J. Tissue localization of radioactive chlormadinone acetate and progesterone in the human. Contraception 1 (1970) 151-161
14. Hamilton B.E., Sutton P.D., and Ventura S.J. Revised birth and fertility rates for the 1990s and new rates for Hispanic populations, 2000 and 2001: United States. Natl Vital Stat Rep 51 (2003) 1-94
15. Larsen U., and Yan S. The age pattern of fecundability: an analysis of French Canadian and Hutterite birth histories. Soc Biol 47 (2000) 34-50
16. Wood J.W. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol 11 (1989) 61-109
17. Cronin M., Möhner S., Minh Thai D., and Westhoff C. Past oral contraception use does not negatively affect time to conception. Obstet Gynecol 109 (2007) 3S
18. Trussell J. Methodological pitfalls in the analysis of contraceptive failure. Stat Med 10 (1991) 201-220
19. Howe G., Westhoff C., Vessey M., and Yeates D. Effects of age, cigarette smoking, and other factors on fertility: findings in a large prospective study. Br Med J (Clin Res Ed) 290 (1985) 1697-1700
20. Cronin M., Möhner S., Dinger J., and Schellschmidt I. Return to fertility after use of oral contraceptives: results from the EURAS study. Proceedings of the 9th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI). Barcelona, Spain, March 22-25, 2007 (2007) A-68
21. Nyholm M., Gullberg B., Merlo J., Lundqvist-Persson C., Rastam L., and Lindblad U. The validity of obesity based on self-reported weight and height: Implications for population studies. Obesity (Silver Spring) 15 (2007) 197-208
22. Visscher T.L., Viet A.L., Kroesbergen I.H., and Seidell J.C. Underreporting of BMI in adults and its effect on obesity prevalence estimations in the period 1998 to 2001. Obesity (Silver Spring) 14 (2006) 2054-2063
23. Kost K., Singh S., Vaughan B., Trussell J., and Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 77 (2008) 10-21
24. Darney P. Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials. Contraception 48 (1993) 323-337
25. Ferguson H., Vree M.L., Wilpshaar J., and Eskes T.K. Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive. Eur J Contracept Reprod Health Care 5 (2000) 35-45
26. Grubb G.S., Archer D.F., and Constantine G.D. Differences between the United States and Europe in clinical trials of hormonal contraceptive efficacy. Obstet Gynecol 111 (2008) 63S
27. Salas M., Kiefe C.I., Schreiner P.J., et al. Obesity modifies the association of race/ethnicity with medication adherence in the CARDIA study. The Patient 1 (2008) 41-54